2017-18<\/p><\/td> | £3,224<\/p><\/td><\/tr><\/tbody><\/table> <\/p> The data source for the table is from reference costs, which are the average unit costs to NHS trusts and NHS foundation trusts of providing defined services in a given financial year to NHS patients. Cost data provided includes:<\/p> - Those that relate to the following treatment function code (TFC):<\/p> - 260 - Paediatric medical oncology<\/p> - 370 - Medical oncology<\/p> - 503 - Gynaecological oncology<\/p> - 800 - Clinical oncology (previously radiotherapy);<\/p> <\/p> - Cancer multi-disciplinary team meetings;<\/p> - Chemotherapy and radiotherapy services; and<\/p> - Cancer related community health services.<\/p> This may not cover all costs associated with oncology. There are areas related to oncology where the costs cannot be identified. These would include:<\/p> - Homecare drugs;<\/p> - Diagnostic imaging; and<\/p> - Other cancer related health resource groups (HRGs) in other TFCs.<\/p> <\/p> There are no primary care costs included within the data.<\/p> Data on the number of IT systems used within oncology treatment in the NHS is not available.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-04-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "236367"}
, {"_value" : "236369"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-02T11:24:26.92Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many oncology patients have been registered to receive treatment through the NHS in each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236365"}
, {"_about" : "http://data.parliament.uk/resources/1104693", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104693/answer", "answerText" : {"_value" : " NHS Digital publishes Hospital and Community Health Services workforce statistics. These include staff working in hospital trusts and clinical commissioning groups, but not staff working in primary care, local authorities or other providers.<\/p> <\/p> The latest NHS Digital workforce statistics show that as at 30 December 2018 there are 1,317 doctors with a speciality in clinical oncology and 985 doctors with a speciality in medical oncology. The figures include all doctors working in the specialty of oncology such as consultants, associate specialists, specialty doctors, doctors in training etc.<\/p> <\/p> The latest NHS Digital workforce statistics show that as at 30 December 2018 there are 2,093 nurses who work in an area of \u2018clinical oncology\u2019 and 1,237 nurses who work in an area of \u2018medical oncology\u2019. This data represents nurses who are working in services related to oncology, rather than nurses with specialist training in oncology.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-04-02", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-02T11:43:26.817Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Health Professions"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many (a) nurses and (b) doctors are specifically employed within the oncology speciality.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236366"}
, {"_about" : "http://data.parliament.uk/resources/1104694", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104694/answer", "answerText" : {"_value" : " NHS England holds data in relation to the number of people starting definitive cancer treatment in each year from 2010. This includes people who have received their first cancer treatment in that year, which includes all types of cancer treatment and not just oncological treatments (chemotherapy and radiotherapy).<\/p> <\/p> The number of people receiving their first treatment for cancer each year has risen significantly each year since 2010. It should be noted that the 2018 data is published but includes three months of provisional data, so could be subject to slight adjustment.<\/p> Year<\/p><\/td> | Patients receiving first treatment<\/p><\/td><\/tr> | 2010<\/p><\/td> | 242,396<\/p><\/td><\/tr> | 2011<\/p><\/td> | 252,483<\/p><\/td><\/tr> | 2012<\/p><\/td> | 259,853<\/p><\/td><\/tr> | 2013<\/p><\/td> | 264,437<\/p><\/td><\/tr> | 2014<\/p><\/td> | 271,662<\/p><\/td><\/tr> | 2015<\/p><\/td> | 279,887<\/p><\/td><\/tr> | 2016<\/p><\/td> | 285,894<\/p><\/td><\/tr> | 2017<\/p><\/td> | 295,133<\/p><\/td><\/tr> | 2018<\/p><\/td> | 308,058<\/p><\/td><\/tr> | Total<\/p><\/td> | 2,459,803<\/p><\/td><\/tr><\/tbody><\/table> <\/p> NHS England holds data in relation to specialised commissioning spend that will contribute to the overall spend, from 2013/14 onwards. The financial values have been consolidated through the use of NPoC (National Programme of Care) codes and are taken from our annual spend analysis exercise. This exercise uses Provider Aggregate Contract Monitoring as the basis for the data; where this data is incomplete hubs will apportion / estimate any missing values. The costs for chemotherapy and specialised cancer surgery have been combined for 2013/14 and 2014/15.<\/p> <\/p><\/td> | 2013/14<\/p><\/td> | 2014/15<\/p><\/td> | 2015/16<\/p><\/td> | 2016/17<\/p><\/td> | 2017/18<\/p><\/td><\/tr> | NPoC<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td><\/tr> | B01 - Radiotherapy<\/p><\/td> | 340.2<\/p><\/td> | 315.2<\/p><\/td> | 368.5<\/p><\/td> | 425.0<\/p><\/td> | 390.9<\/p><\/td><\/tr> | B02 - Chemotherapy<\/p><\/td> | 1,730.8<\/p><\/td> | 2,305.9<\/p><\/td> | 1,417.1<\/p><\/td> | 1,858.3<\/p><\/td> | 2,014.8<\/p><\/td><\/tr> | B03 - Specialised cancer surgery<\/p><\/td> | 1,071.3<\/p><\/td> | 806.3<\/p><\/td> | 1,240.5<\/p><\/td><\/tr> | B04 - Specialised cancer diagnostics<\/p><\/td> | 56.3<\/p><\/td> | 66.3<\/p><\/td> | 78.3<\/p><\/td> | 78.1<\/p><\/td> | 98.2<\/p><\/td><\/tr> | B05 - Children and young adult cancer services<\/p><\/td> | 79.9<\/p><\/td> | 94.0<\/p><\/td> | 121.9<\/p><\/td> | 124.1<\/p><\/td> | 178.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 2,207.2<\/p><\/td> | 2,781.4<\/p><\/td> | 3,057.1<\/p><\/td> | 3,291.8<\/p><\/td> | 3,923.1<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Additionally, as a further indication toward total spend, NHS Improvement estimates the total cost to National Health Service trusts and NHS foundation trusts for providing oncological treatment as follows.<\/p> Year<\/p><\/td> | Estimated total cost (£ million)<\/p><\/td><\/tr> | 2010-11<\/p><\/td> | £1,801<\/p><\/td><\/tr> | 2011-12<\/p><\/td> | £2,051<\/p><\/td><\/tr> | 2012-13<\/p><\/td> | £2,259<\/p><\/td><\/tr> | 2013-14<\/p><\/td> | £2,457<\/p><\/td><\/tr> | 2014-15<\/p><\/td> | £2,706<\/p><\/td><\/tr> | 2015-16<\/p><\/td> | £2,864<\/p><\/td><\/tr> | 2016-17<\/p><\/td> | £2,955<\/p><\/td><\/tr> | 2017-18<\/p><\/td> | £3,224<\/p><\/td><\/tr><\/tbody><\/table> <\/p> The data source for the table is from reference costs, which are the average unit costs to NHS trusts and NHS foundation trusts of providing defined services in a given financial year to NHS patients. Cost data provided includes:<\/p> - Those that relate to the following treatment function code (TFC):<\/p> - 260 - Paediatric medical oncology<\/p> - 370 - Medical oncology<\/p> - 503 - Gynaecological oncology<\/p> - 800 - Clinical oncology (previously radiotherapy);<\/p> <\/p> - Cancer multi-disciplinary team meetings;<\/p> - Chemotherapy and radiotherapy services; and<\/p> - Cancer related community health services.<\/p> This may not cover all costs associated with oncology. There are areas related to oncology where the costs cannot be identified. These would include:<\/p> - Homecare drugs;<\/p> - Diagnostic imaging; and<\/p> - Other cancer related health resource groups (HRGs) in other TFCs.<\/p> <\/p> There are no primary care costs included within the data.<\/p> Data on the number of IT systems used within oncology treatment in the NHS is not available.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-04-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "236365"}
, {"_value" : "236369"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-02T11:24:27Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how much the NHS spent on providing oncological treatment in each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236367"}
, {"_about" : "http://data.parliament.uk/resources/1104695", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104695/answer", "answerText" : {"_value" : " Neither the Department nor the National Health Service calculate a single estimate of inefficiency in the National Health Service. However, significant work in recent years has gone into calculating unwarranted variation in the NHS.<\/p> <\/p> The Lord Carter reviews into unwarranted variation, published in 2016-18, identified £5.8 billion of recurrent savings. These reports identified variation in service delivery, to quantify potential savings, noting that some variation is warranted and desirable, when different circumstances require it.<\/p> <\/p> In 2017/18, the NHS made £1.45 billion of efficiency savings, by enacting the recommendations of the Carter report and reducing unwarranted variation. Central support was delivered to trusts across a range of programmes, including the clinical workforce, diagnostics, pharmacy, back-office services, estates and procurement. Trusts have identified further opportunities beyond this, at a local level, and have been supported by the Department and NHS Improvement to deliver these additional savings.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1585", "label" : {"_value" : "Biography information for Stephen Hammond"}
}
, "answeringMemberConstituency" : {"_value" : "Wimbledon"}
, "answeringMemberPrinted" : {"_value" : "Stephen Hammond"}
, "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-01T15:20:47.76Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "NHS: Cost Effectiveness"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what the estimated cost of inefficiency in the NHS has been in each year since 2010.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236368"}
, {"_about" : "http://data.parliament.uk/resources/1104696", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104696/answer", "answerText" : {"_value" : " NHS England holds data in relation to the number of people starting definitive cancer treatment in each year from 2010. This includes people who have received their first cancer treatment in that year, which includes all types of cancer treatment and not just oncological treatments (chemotherapy and radiotherapy).<\/p> <\/p> The number of people receiving their first treatment for cancer each year has risen significantly each year since 2010. It should be noted that the 2018 data is published but includes three months of provisional data, so could be subject to slight adjustment.<\/p> Year<\/p><\/td> | Patients receiving first treatment<\/p><\/td><\/tr> | 2010<\/p><\/td> | 242,396<\/p><\/td><\/tr> | 2011<\/p><\/td> | 252,483<\/p><\/td><\/tr> | 2012<\/p><\/td> | 259,853<\/p><\/td><\/tr> | 2013<\/p><\/td> | 264,437<\/p><\/td><\/tr> | 2014<\/p><\/td> | 271,662<\/p><\/td><\/tr> | 2015<\/p><\/td> | 279,887<\/p><\/td><\/tr> | 2016<\/p><\/td> | 285,894<\/p><\/td><\/tr> | 2017<\/p><\/td> | 295,133<\/p><\/td><\/tr> | 2018<\/p><\/td> | 308,058<\/p><\/td><\/tr> | Total<\/p><\/td> | 2,459,803<\/p><\/td><\/tr><\/tbody><\/table> <\/p> NHS England holds data in relation to specialised commissioning spend that will contribute to the overall spend, from 2013/14 onwards. The financial values have been consolidated through the use of NPoC (National Programme of Care) codes and are taken from our annual spend analysis exercise. This exercise uses Provider Aggregate Contract Monitoring as the basis for the data; where this data is incomplete hubs will apportion / estimate any missing values. The costs for chemotherapy and specialised cancer surgery have been combined for 2013/14 and 2014/15.<\/p> <\/p><\/td> | 2013/14<\/p><\/td> | 2014/15<\/p><\/td> | 2015/16<\/p><\/td> | 2016/17<\/p><\/td> | 2017/18<\/p><\/td><\/tr> | NPoC<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td> | £ million<\/p><\/td><\/tr> | B01 - Radiotherapy<\/p><\/td> | 340.2<\/p><\/td> | 315.2<\/p><\/td> | 368.5<\/p><\/td> | 425.0<\/p><\/td> | 390.9<\/p><\/td><\/tr> | B02 - Chemotherapy<\/p><\/td> | 1,730.8<\/p><\/td> | 2,305.9<\/p><\/td> | 1,417.1<\/p><\/td> | 1,858.3<\/p><\/td> | 2,014.8<\/p><\/td><\/tr> | B03 - Specialised cancer surgery<\/p><\/td> | 1,071.3<\/p><\/td> | 806.3<\/p><\/td> | 1,240.5<\/p><\/td><\/tr> | B04 - Specialised cancer diagnostics<\/p><\/td> | 56.3<\/p><\/td> | 66.3<\/p><\/td> | 78.3<\/p><\/td> | 78.1<\/p><\/td> | 98.2<\/p><\/td><\/tr> | B05 - Children and young adult cancer services<\/p><\/td> | 79.9<\/p><\/td> | 94.0<\/p><\/td> | 121.9<\/p><\/td> | 124.1<\/p><\/td> | 178.8<\/p><\/td><\/tr> | Total<\/p><\/td> | 2,207.2<\/p><\/td> | 2,781.4<\/p><\/td> | 3,057.1<\/p><\/td> | 3,291.8<\/p><\/td> | 3,923.1<\/p><\/td><\/tr><\/tbody><\/table> <\/p> Additionally, as a further indication toward total spend, NHS Improvement estimates the total cost to National Health Service trusts and NHS foundation trusts for providing oncological treatment as follows.<\/p> Year<\/p><\/td> | Estimated total cost (£ million)<\/p><\/td><\/tr> | 2010-11<\/p><\/td> | £1,801<\/p><\/td><\/tr> | 2011-12<\/p><\/td> | £2,051<\/p><\/td><\/tr> | 2012-13<\/p><\/td> | £2,259<\/p><\/td><\/tr> | 2013-14<\/p><\/td> | £2,457<\/p><\/td><\/tr> | 2014-15<\/p><\/td> | £2,706<\/p><\/td><\/tr> | 2015-16<\/p><\/td> | £2,864<\/p><\/td><\/tr> | 2016-17<\/p><\/td> | £2,955<\/p><\/td><\/tr> | 2017-18<\/p><\/td> | £3,224<\/p><\/td><\/tr><\/tbody><\/table> <\/p> The data source for the table is from reference costs, which are the average unit costs to NHS trusts and NHS foundation trusts of providing defined services in a given financial year to NHS patients. Cost data provided includes:<\/p> - Those that relate to the following treatment function code (TFC):<\/p> - 260 - Paediatric medical oncology<\/p> - 370 - Medical oncology<\/p> - 503 - Gynaecological oncology<\/p> - 800 - Clinical oncology (previously radiotherapy);<\/p> <\/p> - Cancer multi-disciplinary team meetings;<\/p> - Chemotherapy and radiotherapy services; and<\/p> - Cancer related community health services.<\/p> This may not cover all costs associated with oncology. There are areas related to oncology where the costs cannot be identified. These would include:<\/p> - Homecare drugs;<\/p> - Diagnostic imaging; and<\/p> - Other cancer related health resource groups (HRGs) in other TFCs.<\/p> <\/p> There are no primary care costs included within the data.<\/p> Data on the number of IT systems used within oncology treatment in the NHS is not available.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4008", "label" : {"_value" : "Biography information for Dame Caroline Dinenage"}
}
, "answeringMemberConstituency" : {"_value" : "Gosport"}
, "answeringMemberPrinted" : {"_value" : "Caroline Dinenage"}
, "dateOfAnswer" : {"_value" : "2019-04-02", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "236365"}
, {"_value" : "236367"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-02T11:24:27.077Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Cancer: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, how many IT systems are used within oncological treatment in the NHS.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236369"}
, {"_about" : "http://data.parliament.uk/resources/1104697", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104697/answer", "answerText" : {"_value" : " The Sport Business Council (SBC) has explored a number of priority areas for the sector, such as intellectual property, event staging, sector skills, and local partnerships, and has established the importance of engaging with the sports economy I intend to consider the work to date of the SBC, and continue engagement with the business of sport in the months ahead.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4513", "label" : {"_value" : "Biography information for Mims Davies"}
}
, "answeringMemberConstituency" : {"_value" : "Eastleigh"}
, "answeringMemberPrinted" : {"_value" : "Mims Davies"}
, "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-01T09:15:27.85Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sports Business Council"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what the outcomes were from the meetings of the Sports Business Council held between June 2017 and April 2018; and when the council next plans to meet.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236370"}
, {"_about" : "http://data.parliament.uk/resources/1104698", "AnsweringBody" : [{"_value" : "Department for Digital, Culture, Media and Sport"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1104698/answer", "answerText" : {"_value" : " I continue to meet regularly with my ministerial colleagues as well as officials and representatives in Northern Ireland to discuss our joint working on healthy living including sport and physical activity. I intend to consider the work to date of the Sports Business Council, and continue engagement with sport as an economic sector in the months ahead.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4513", "label" : {"_value" : "Biography information for Mims Davies"}
}
, "answeringMemberConstituency" : {"_value" : "Eastleigh"}
, "answeringMemberPrinted" : {"_value" : "Mims Davies"}
, "dateOfAnswer" : {"_value" : "2019-04-01", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-04-01T09:16:17.337Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "10"}
, "answeringDeptShortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "answeringDeptSortName" : {"_value" : "Digital, Culture, Media and Sport"}
, "date" : {"_value" : "2019-03-25", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Healthy Living Ministerial Group and Sports Business Council"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Digital, Culture, Media and Sport, what plans the Government has to maintain the Inter-Ministerial Group for Healthy Living and the Sports Business Council.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4131", "label" : {"_value" : "Biography information for Jim Shannon"}
}
, "tablingMemberConstituency" : {"_value" : "Strangford"}
, "tablingMemberPrinted" : [{"_value" : "Jim Shannon"}
], "uin" : "236371"}
], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?date=2019-03-25&_page=1&houseId=1&max-questionFirstAnswered.=2019-09-09T14%3A42%3A22.527Z", "page" : 0, "startIndex" : 1, "totalResults" : 355, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|
|
|
|
|
|
|